Back to newsWedbush raises Arcus Biosciences target price to $49 from $43RRCUS•2026-10-21Wedbush raised its target price for Arcus Biosciences to $49 from $43.Related NewsGGeron to report third-quarter financial resultsGERN•2026-10-21CCrowdStrike, Nvidia expand AI agent security from software to siliconCRWD•2026-10-21SSpaceX is stuck in a difficult adolescenceSPCX•2026-10-21IImunon agrees to sell ThermoDox rights to VoxelDox TherapeuticsIMNN•2026-10-21TTwin Disc publishes update to financial calendarTWIN•2026-10-21
RCUS•RCUS•RCUS•RCUS•
